• Adedayo Onitilo MD, PhD, MSCR, FACP

  • Physician - Hematology/Oncology


    • WES-Oncology
    • 3501 Cranberry Boulevard WES Weston, WI 54476

Education


1995:
MD, Ogun State University, Sagamu, Ogun State, Nigeria
1996:
Internship, Rotations in Medicine and Pediatrics, Ogun State University Teaching Hospital, Sagamu, Nigeria
1997:
Internship, Rotations in Medicine, Pediatrics, Obstetrics & Gynecology and Surgery, General Hospital St. George's Grenada in affiliation with St. George's University School of Medicine, Grenada, West Indies
1998:
Clinical Experience, Medical Officer/ER Physician, The General Hospital, St. George and Princess Alice Hospital, St. Andrews, Grenada, West Indies
1999:
Internship, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
2001:
Residency, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
2004:
MSCR, Master of Science in Clinical Science, Medical University of South Carolina, Charleston, SC
2004:
Fellowship, Oncology/Hematology, Medical University of South Carolina, Charleston, SC
2014:
PhD, University of Queensland, Brisbane, Queensland, Australia

Work Experience


2004 to 2005:
Oncologist / Hematologist, Marshfield Clinic Inc. - Wausau Center, Wausau, WI
2004 to 2007:
Oncologist / Hematologist, Wausau Hospital, Wausau, WI
2005 to 2012:
Assistant Director of Clinical Research, Marshfield Clinic Research Foundation, Eastern Division
2005 to 2013:
Clinical Assistant Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2009 to 2014:
CO-Investigator, Community Oncology Research Program (CCOP), Marshfield, WI
2014 to 2015:
CO-Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2005 to 2017:
Attending Physician, Ascension St. Michael's Hospital, Stevens Point, WI
2005 to Present:
Oncologist / Hematologist, Ascension Saint Clare's Hospital, Weston, WI
2005 to Present:
Oncologist / Hematologist, Marshfield Clinic Inc. - Weston Center, Weston, WI
2007 to Present:
Associate Editor, Clinical Medicine and Research, Marshfield Clinic Inc. - Marshfield Center, Marshfield, WI
2007 to Present:
Director, Breast Program, Marshfield Clinic Inc. , Eastern Division, WI
2009 to Present:
Mentor, Physician Mentorship Program, Marshfield Clinic Inc., Weston, WI
2010 to Present:
Chair, Hematology / Oncology Department, Marshfield Clinic Inc., Eastern Division
2013 to Present:
Clinical Associate Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2014 to Present:
Oncology Service Line Leader, Marshfield Clinic Inc. - Marshfield Center, Marshfield, WI
2015 to Present:
Principal Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2017 to Present:
Oncologist / Hematologist, Marshfield Clinic Inc. - Stevens Point Center, Steven's Point, WI
2017 to Present:
Attending Physician, Marshfield Clinic Inc. - Merrill Center, Merrill, WI

Statement


"Patients always come first for me. I treat everyone as relatives and friends. I will give everyone my best, every time, every day!"


Select Publications


  • Onitilo AA. Social costs and medical benefits of genetic information on sickle-cell disease. Pugwash Guidebook. 1994;
  • Onitilo AA. Pernicious anemia presenting as fever, diarrhea, jaundice, anemia and hyperpigmentation. Grenada Medical Journal. 1998;2 :1.
  • Onitilo AA, Olatosi AO, Igbal J, Capps LG. Preoperative cardiac risk assessment prior to ambulatory surgery. J Gen Int Med. 2001 Apr;16(1):161.
  • Onitilo AA, Lazarchick J, Brunson CY, Frei-Lahr D, Stuart RK. Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc. 2003 Dec;35(8):3089-3092.
    PubMed ID: 14697986
  • Kio EA, Onitilo AA, Lazarchick J, Hanna M, Brunson CY, Chaudhary BA. Sickle cell crisis associated with hemophagocytic lymphohistiocytosis. Am J Hematol. 2004 Nov;77(3):229-232.
    PubMed ID: 15495257
  • Onitilo AA, Lin YH, Okonofua EC, Afrin LB, Ariail J, Tilley BC. Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians. Transplant Proc. 2004 Dec;36(10):3212-3219.
    PubMed ID: 15686731
  • Chaudhary UB, Rashid MH, Onitilo AA, Bissada NK. Secondary hormonal manipulations in the management of advanced prostate cancer. Can J Urol. 2005 Jun;12(3):2666-2676.
    PubMed ID: 16011813
  • Onitilo AA, Kio EA, Singh AK, Lazarchick J. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leuk Lymphoma. 2005 Nov;46(11):1667-1670.
    PubMed ID: 16236620
  • Onitilo AA, Shaw GR. Parvovirus B19 infection in an isolated pancreas transplant recipient. Transplant Proc. 2005 Dec;37(10):4433-4435.
    PubMed ID: 16387138
  • Onitilo AA, Skorupa A, Lal A, Ronish E, Mercier RJ, Islam R, Lazarchick J. Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 2006 Jul;96(1):84-87.
    PubMed ID: 16807656
  • Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006 Sep;28(5):396-402.
    PubMed ID: 16950374
  • Onitilo AA. Delayed profound thrombocytopenia associated with eptifibatide. Am J Hematol. 2006 Dec;81(12):984.
    PubMed ID: 16804935
  • Onitilo AA, Engel JM, Olatosi B, Fagbemi SO. Community experience with bortezomib in patients with multiple myeloma. Am J Hematol. 2007 Jul;82(7):637-639.
    PubMed ID: 17301970
  • Doi SA. R., Woodhouse NJ., Thalib L, Onitilo AA. Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited. Clin Med Res. 2007 Jun;5(2):87-90.
    PubMed ID: 17607042
  • Huncharek MS, Muscat J, Onitilo AA, Kupelnick B. Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies. Eur J Cancer Prev. 2007 Oct;16(5):422-429.
    PubMed ID: 17923813
  • Onitilo AA. Study examines breast cancer drug effectiveness. Personalized Medicine. 2007;2(2):1, 4.
  • Onitilo AA, Kio EA, Doi SA. R.. Tumor-related hyponatremia. Clinical Medicine & Research. 2007 Dec;5(4):218-26.
    PubMed ID: 18086907
  • Onitilo AA. Testicular microlithiasis: another starry sky appearance. Clinical Medicine & Research. 2007 Sep;5(3):163-164.
    PubMed ID: 18056024
  • Onitilo AA, Engel JM, Demos JM, Mukesh BNanjan. Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. Clinical Medicine & Research. 2008 Sep;6(2):72 -77.
    PubMed ID: 18801952
  • Ghbeis M, Onitilo AA, Greenlee RT, Vidaillet HJ. Abstract 3131: Primary Cardiac Malignant Tumors. Incidence, Trends and Survival. CIRCULATION. 2008;118(S):1098-S_1099.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. Breast cancer subtypes based on ER/PR and HER2 expression: A population-based experience. JOURNAL OF CLINICAL ONCOLOGY. 2008 May;May 20 suppl; abstr 22181
  • Engel JM, Onitilo AA, Demos JM, Mukesh BNanjan. Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. 2008 May;26:2008(May 20 suppl; abstr 7591)
  • Onitilo AA, Engel JM. Managing Relapse of CML Using Therapeutic Imatinib Plasma Level Clin Adv Hematol Oncol. 2009 Nov;7(11):763-7.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res. 2009 Jun;7(1-2):4-13.
    PubMed ID: 19251585
  • Doi SA. R., Onitilo AA. Author Reply Clinical Medicine & Research. 2009 Jun;7(1-2):2-3.
  • Onitilo AA, McCarty CA, Wilke RA, Glurich IE, Engel JM, Flockhart DA, Nguyen A, Li L, Mi D, Skaar TC, Gin Y. Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 2009 Jun;115(3):643-50.
    PubMed ID: 19082882
  • Onitilo AA, Engel JM, Lundgren CIhre, Hall P, Thalib L, Doi SA. R.. Simplifying the TNM system for clinical use in differentiated thyroid cancer. JOURNAL OF CLINICAL ONCOLOGY. 2009 Apr;27(11):1872-8.
    PubMed ID: 19273697
  • Onitilo AA, Engel JM, Clouse LH, Gerndt KM. Successful Treatment of Mitomycin-induced Thrombotic Thrombocytopenic Purpura with Rituximab. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2009 Feb;20(2):275-6.
    PubMed ID: 19054690
  • Doi SA. R., Engel JM, Onitilo AA. Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma. Clin Nucl Med. 2010 Jun;35(6):396-9.
    PubMed ID: 20479583
  • Feigelson HS, Bischoff K, Bowles E, Engel JM, James T, Onitilo AA, Single R, Williams A, Wagner E, McCahill L. PS2-24: Improving Breast Cancer Surgery Quality Through a Collaborative Surgical Database Clinical Medicine & Research. 2010 Dec;8(3-4):180.
  • Onitilo AA, Engel JM, Resnick JM. Prostate carcinoma metastatic to the stomach: report of two cases and review of the literature. Clinical Medicine & Research. 2010 Mar;8(1):18-21.
    PubMed ID: 20305145
  • Onitilo AA, Engel JM, Tanimu SB, Nguyen TT. Anthracosis and Large Mediastinal Mass in a Patient with Healed Pulmonary Tuberculosis. Clinical Medicine & Research. 2010 Jul;8(2):99-103.
  • Feigelson HS, Goddard KA, Rahm A, Pawloski P, McCarty CA, Onitilo AA, Lawrence K, Davis R, Potosky A. PS1-14: Utilization and Effectiveness of KRAS Testing for Colorectal Cancer Clinical Medicine & Research. 2010 Dec;8(3-4):192.
  • Onitilo AA, Engel JM, Sajjad SM. The possible role of hemochromatosis in testicular cancer. MEDICAL HYPOTHESES. 2011 Aug;77(2):179-81.
    PubMed ID: 21549511
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M, Nekhlyudov L, Goddard KA, Davis R, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. C-C1-02: Validity of HMO Administrative Data for Breast Cancer Chemotherapy Exposure. Clinical Medicine & Research. 2011 Nov;9(3-4):146.
  • Depke JL, Onitilo AA. Coalition building and the Intervention Wheel to address breast cancer screening in Hmong women. Clinical Medicine & Research. 2011 Mar;9(1):1-9.
    PubMed ID: 21441527
  • Bowles E, Feigelson HS, Sterrett A, Barney T, Broecker K, Bischoff K, Engel JM, Gundersen G, James T, Onitilo AA, McCahill L. PS2-03: Improving Quality Of Breast Cancer Surgery Through Development of a National Breast Cancer Surgical Outcomes Database. Clinical Medicine & Research. 2011 Nov;9(3-4):144.
    PubMed ID: 22090527
  • Bowles E, Wellman R, Delate T, Allen L, Feigelson HS, Yood M, Davis R, Nekhlyudov L, McCarty CA, Habel L, Magid DJ, Onitilo AA, Freedman A, Wagner E. C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network Clinical Medicine & Research. 2011 Nov;9(3-4):148.
  • Onitilo AA, Engel JM, Berg RL. C-B2-02: Epidemiology of Tamoxifen and Thromboembolism Clinical Medicine & Research. 2011 Nov;9(3-4):150.
    PubMed ID: 22090543
  • Klimant E, Glurich IE, Mukesh BNanjan, Onitilo AA. Blood type, hormone receptor status, her2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clinical Medicine & Research. 2011 Nov;9(3-4):111-8.
    PubMed ID: 21263059
  • Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking WG, Yale SH, Mazza JJ. Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis. 2012 Oct;2012 :142615.
    PubMed ID: 23213505
  • Rocque G, Onitilo AA, Engel JM, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME. Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat. 2012 Jan;131(2):713-21.
    PubMed ID: 22065290
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M, Nekhlyudov L, Goddard KA, Davis R, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure. Cancer Epidemiol Biomarkers Prev.. 2012 Apr;21(4):673-80.
    PubMed ID: 22337532
  • Onitilo AA, Demos JM, Depke JL, Resnick JM, Engel JM. Digital ischemia as a paraneoplastic consequence of squamous cell lung carcinoma. WMJ. 2012 Jun;111(3):138-42; quiz 142.
  • Aiello Bowles E, Wellman R, Feigelson HS, Onitilo AA, Freedman A, Delate T, Allen L, Nekhlyudov L, Goddard KA, Davis R, Habel L, Yood M, McCarty CA, Magid DJ, Wagner E, for the Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst.. 2012 Aug;104(17):1293-305.
    PubMed ID: 22949432
  • Onitilo AA, Govinda A, Engel JM. Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review. Clin Adv Hematol Oncol. 2012 Oct;10(10):689-91.
    PubMed ID: 23187778
  • Feigelson HS, Onitilo AA, James T, Bowles EA, Single R, Barney T, Engel JM, McCahill L. CA2-04: Variation in Mastectomy Rate for Invasive Breast Cancer: Results from the Breast Cancer Surgical Outcomes Study. Clinical Medicine & Research. 2012 Aug;10(3):151-2.
    PubMed ID: 22904404
  • Onitilo AA, Engel JM, Feigelson HS, Bowles EA, Single R, James T, McCahill L. PS1-16: Patterns of Surgical Care for Ductal Carcinoma In-situ. Clinical Medicine & Research. 2012 Aug;10(3):148.
    PubMed ID: 22904394
  • Goddard KA, Aiello Bowles E, Spencer Feigelson H, Habel LA, Alford S, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm A, Webster J. Utilization of HER2 genetic testing in a multi-institutional observational study. AMERICAN JOURNAL OF MANAGED CARE. 2012 Nov;18(11):704-12.
    PubMed ID: 23198713
  • Onitilo AA. The debate over lifesaving benefit of screening mammography continues. ARCHIVES OF INTERNAL MEDICINE. 2012 Mar;172(5):446-7.
    PubMed ID: 22412117
  • Bowles E, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K, Engel JM, Gundersen G, Sheehey-Jones J, Single R, Onitilo AA, James T, McCahill L. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC CANCER. 2012 Apr;12(1):136.
    PubMed ID: 22472011
  • Onitilo AA, Engel JM, Stankowski RV, Liang H, Berg RL, Doi SA. R.. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. BREAST CANCER RESEARCH AND TREATMENT. 2012 Jul;134(1):291-8.
    PubMed ID: 22476854
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 2012 Jul;23(7):991-1008.
    PubMed ID: 22527174
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams GH, Doi SA. R.. Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 2012 Jun;23(6):967-81.
    PubMed ID: 22552844
  • McCahill L, Single R, Aiello Bowles E, Feigelson HS, James T, Barney T, Engel JM, Onitilo AA. Variability in reexcision following breast conservation surgery. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2012 Feb;307(5):467-75.
    PubMed ID: 22298678
  • Onitilo AA, Doi SA. R.. Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. NUCLEAR MEDICINE COMMUNICATIONS. 2012 Oct;33(11):1217-8.
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Johnson JC, Berg RL. Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 2012 Jul;130(1):27-31.
    PubMed ID: 22154240
  • Onitilo AA, Doi SA. R., Barendregt JJ. Meta-analysis II In: Doi, Suhail; Williams, Gail M., Methods of Clinical Epidemiology Textbook Springer, 2013
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. R.. Reliability of reviewer ratings in the manuscript peer review process: an opportunity for improvement. Account Res. 2013 Jun;20(4):270-84.
    PubMed ID: 23805832
  • Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak D, Broton M, Doi SA. R.. Mammography Utilization: Patient Characteristics and Breast Cancer Stage at Diagnosis. AJR Am J Roentgenol. 2013 Nov;201(5):1057-63.
    PubMed ID: 23952790
  • Liu J, Page D, Nassif H, Peissig PL, McCarty CA, Onitilo AA, Burnside E. Genetic variants improve breast cancer risk prediction on mammograms. AMIA Annu Symp Proc. 2013 Nov;2013(eCollection 2013):876-85.
    PubMed ID: 24551380
  • Tanimu SB, Rafiullah, Resnick JM, Onitilo AA. Peripancreatic cystic lymphangioma diagnosed by endoscopic ultrasound/fine-needle aspiration: a rare mesenchymal tumour. BMJ Case Rep. 2013 Oct; :pii: bcr2013200210.
    PubMed ID: 24092605
  • Doi SA. R., Barendregt JJ, Onitilo AA. Methods for the bias adjustment of meta-analyses of published observational studies. J Eval Clin Pract. 2013 Aug;19(4):653-7.
    PubMed ID: 22845171
  • Webster J, Kauffman TL, Spencer Feigelson H, Pawloski PA, Onitilo AA, Potosky AL, Cross DS, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA. KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings. Cancer Epidemiol Biomarkers Prev.. 2013 Jan;22(1):91-101.
    PubMed ID: 23155138
  • Onitilo AA, Kar P, Engel JM, Glurich IE. Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 2013 Apr;104(2):141-53.
    PubMed ID: 23514990
  • Feigelson HS, James T, single RM, Onitilo AA, Aiello Bowles E, Barney T, Bakerman JE, McCahill L. Factors Associated with the Frequency of Initial Total Mastectomy: Results of a Multi-Institutional Study. J Am Coll Surg. 2013 May;216(5):966-75.
    PubMed ID: 23490543
  • Onitilo AA, Donald M, Stankowski RV, Engel JM, Williams G, Doi SA. R.. Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study. Clinical Medicine & Research. 2013 Dec;11(4):210-8.
    PubMed ID: 23669614
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 2013 Dec;11(4):201-9.
    PubMed ID: 23656798
  • Glurich IE, Chyou P, Engel JM, Cross DS, Onitilo AA. Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 2013 Feb;11(1):16-25.
    PubMed ID: 23411630
  • Onitilo AA, Aryal G, Engel JM. Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment. Clinical Medicine & Research. 2013 Feb;11(1):36-41.
    PubMed ID: 22723466
  • Onitilo AA, Engel JM. A New NF1 Variant in a Patient with Atypical Manifestations. American Journal of Medical Genetics Part A. 2013 Feb;161(2):389-92.
    PubMed ID: 23322702
  • Onitilo AA, Stankowski RV, Engel JM, Doi SA. R.. Adequate lymph node recovery improves survival in colorectal cancer patients. Journal of Surgical Oncology. 2013 Jun;107(8):828-34.
    PubMed ID: 23592545
  • Cross DS, Rahm A, Kauffman TL, Webster J, Le A, Spencer Feigelson H, Alexander GL, Meier P, Onitilo AA, Pawloski PA, Williams A, Honda S, Daida Y, McCarty CA, Goddard KA. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. GENETICS IN MEDICINE. 2013 Dec;15(12):933-40.
    PubMed ID: 23639899
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 2013 Jun;131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 2013 Aug;8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Onesti J, Single R, Engel JM, James T, Aiello Bowles E, Spencer Feigelson H, Barney T, McCahill L. Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer PLoS One. 2013 Dec;8(12):e84535.
  • Braden AM, Stankowski RV, Engel JM, Onitilo AA. Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence. Curr Pharm Des. 2014 Dec;20(30):4879-98.
    PubMed ID: 24283956
  • Onitilo AA, Engel JM, Salzman SA, Stankowski RV, Doi SA. R.. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014;21(2):109-21.
    PubMed ID: 24228975
  • Stankowski-Drengler TJ, Stankowski RV, Engel JM, Onitilo AA. The Relationship of Type 2 Diabetes, Oral Diabetes Medications, and Insulin Therapy to Risk for Breast Cancer Curr Nutr Rep. 2014 Mar;3(1):1-8.
  • Tanimu SB, Rafiullah, Resnick JM, Onitilo AA. Oesophageal papillomatosis, not amenable to endoscopic therapies, treated with oesophagectomy. BMJ Case Reports. 2014 Apr;2014 :pii: bcr2013200195.
    PubMed ID: 24789149
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Williams GH, Doi SA. R.. A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record. BMC Medical Informatics & Decision Making. 2014 May;14(1):38.
    PubMed ID: 24886371
  • Rafiullah, Tanimu SB, Onitilo AA. Gangliocytic paraganglioma, a rare ampullary tumour treated with open transduodenal resection and sphincteroplasty. BMJ Case Rep. 2014 Jul;2014 :pii: bcr2013202941.
    PubMed ID: 25100803
  • Onitilo AA, Liang H, Stankowski RV, Engel JM, Broton M, Doi SA. R., Miskowiak D. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis Rural Remote Health. 2014 Jul;14(3):2738.
    PubMed ID: 25018129
  • Onitilo AA, Engel JM, Stankowski RV. Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. Ther Adv Drug Saf. 2014 Aug;5(4):154-66.
    PubMed ID: 25083270
  • Dart RA, Onitilo AA, Salzman SA, Reed KD, Shukla SK. Ten years of Clinical Medicine & Research. Clin Med Res. 2014 Sep;12(1-2):1.
  • Onitilo AA. Is it time for the cochrane collaboration to reconsider its meta-analysis methodology? Clin Med Res.. 2014 Sep;12(1-2):2-3.
  • Liu J, Peissig PL, McCarty CA, Onitilo AA, Trentham-Dietz A, Burnside E. New genetic variants improve personalized breast cancer diagnosis. AMIA Jt Summits Transl Sci Proc.. 2014 Apr;eCollection 2014 :83-9.
    PubMed ID: 25717406
  • Sanfelippo MJ, Engel JM, Onitilo AA. Antithrombin levels are unaffected by warfarin use. Arch Pathol Lab Med.. 2014 Jul;138(7):967-8.
    PubMed ID: 24979180
  • Stankowski RV, Engel JM, Stankowski-Drengler TJ, Liang H, Onitilo AA. PS2-42: All-cause Mortality is Decreased in Women Undergoing Annual Mammography Screening Before Breast Cancer Diagnosis Clinical Medicine & Research. 2014 Sep;12(1-2):ps2-42.
  • Mankarios D, Baade P, Youl P, Mortimer R, Onitilo AA, Russell A, Doi SA. R.. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. ENDOCRINE. 2014 Jun;46(2):300-308.
    PubMed ID: 24174176
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 Mar;23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 Mar;23(2):76-83.
    PubMed ID: 23571511
  • Allen L, Yood M, Wagner E, Aiello Bowles E, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis R, Onitilo AA, Magid DJ, Pharmacovigilance Research Group. Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer. MEDICAL CARE. 2014 May;52(5):e30-8.
    PubMed ID: 22643199
  • Feigelson HS, zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirends C, Alexander GL, Hwang C, Cross DS, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard K, CERGEN STeam. Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample PLoS One. 2014 May;9(5):e94977.
    PubMed ID: 24788807
  • Wu Y, Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Burnside ES. Comparing the value of mammographic features and genetic variants in breast cancer risk prediction. AMIA Annu Symp Proc. 2014 Nov 14;2014 :1228-37.
    PubMed ID: 25954434
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014;21(2):109-21.
    PubMed ID: 24228975
  • Engel JM, Stankowski-Drengler TJ, Stankowski RV, Liang H, Doi SA. R., Onitilo AA. All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol.. 2015 Apr;204(4):898-902.
    PubMed ID: 25794084
  • Depke JL, Boreen A, Onitilo AA. Navigating the Needs of Rural Women with Breast Cancer: A Breast Care Program. Clin Med Res. 2015 Dec;13(3-4):149-55.
    PubMed ID: 26056376
  • Onitilo AA, Engel JM, Stankowski RV, Doi SA. R.. Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research. 2015 Jun;13(2):65-73.
    PubMed ID: 25487237
  • Shanle EK, Onitilo AA, Huang W, Kim K, Zang C, Engel JM, Xu W, Wisinski KB. Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer. Am J Transl Res. 2015 Jul 15;7(7):1246-59.
    PubMed ID: 26328009
  • Liu J, Wu Y, Ong I, Page D, Peissig P, McCarty C, Onitilo AA, Burnside E. Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis. AMIA Jt Summits Transl Sci Proc.. 2015 Mar 25;2015 :107-11.
    PubMed ID: 26306250
  • Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. Journal of Medical Imaging. 2015 Aug 17;2(4):041005.
  • Doi SA, Salzman-Scott SA, Onitilo AA. Validation of the CoRE Questionnaire for Medical Journal Peer Review. Account Res. 2016 Jan 20;23(1):47-52.
    PubMed ID: 26192007
  • Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD, Peissig PL, Trentham-Dietz A, Kitchner T, Fan J, Yuan M. Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy. Acad Radiol. 2016 Jan 26;23(1):62-9.
    PubMed ID: 26514439
  • Asare M, Peppone LJ, Roscoe JA, Kleckner IR, Mustian KM, Heckler CE, Guido JJ, Sborov M, Bushunow P, Onitilo A, Kamen C. Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. J Cancer Educ. 2016 Apr 21;
    PubMed ID: 27097806
  • Doi SA, Furuya-Kanamori L, Engel JM, Jamal MH, Stankowski RV, Barkun J, Onitilo AA. The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study. Cancer Causes Control. 2016 May 26;
    PubMed ID: 27228990
  • Wu Y, Abbey CK, Liu J, Ong I, Peissig P, Onitilo AA, Fan J, Yuan M, Burnside ES. Discriminatory power of common genetic variants in personalized breast cancer diagnosis. Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9787
    PubMed ID: 27279675
  • Garg MK, Zhao F, Lee J, Sparano J, Palefsky J, Henry D, Wachsman W, Rajdev L, Aboulafia D, Mitchell E, Onitilo A, El-Rayes B, Nabbout N, Fitzgerald T, Mitsuyasu R, Benson AB, Kachnic LA. Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S106-S107.
    PubMed ID: 27675537
  • Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP, Mulcahy MF, Armstrong KI, Nabbout NH, Kalnicki S, El-Rayes BF, Onitilo AA, Moriarty DJ, Fitzgerald TJ, Benson AB. Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol. 2017 Mar;35(7):718-726.
    PubMed ID: 28068178